We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
Samuel L. Aitken, PharmD, MPH
Advertisement
Articles by Samuel L. Aitken, PharmD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
From Deadly Disease to Chronic Condition: How the Evolution of HIV Treatment Has Allowed People to Live Longer, Better Lives
2
FDA Accepts Shionogi's sNDA to Expand Cefiderocol Use to Pediatric Patients With Drug-Resistant Gram-Negative Infections
3
Two Outbreaks Reveal a Dangerous Double Standard in Global Health
4
Cyclosporiasis: When to Seek Medical Care, Duration of Illness, and Preventive Measures
5